Stay updated on Galunisertib with Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check8 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check15 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1.0%
- Check22 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check51 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check58 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study descriptions and inclusion criteria for a clinical trial involving galunisertib and nivolumab, while adding identifiers and collaborators.SummaryDifference27%
Stay in the know with updates to Galunisertib with Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page.